Literature DB >> 11886244

Quantitative measurement of fusion of HIV-1 and SIV with cultured cells using photosensitized labeling.

Yossef Raviv1, Mathias Viard, Julian Bess, Robert Blumenthal.   

Abstract

The fusion of HIV and SIV with biological membranes was studied by photosensitized activation of a hydrophobic probe, [(125)I]iodonaphthylazide ([(125)I]INA), by a fluorescent lipid which is situated in the target membrane. Photosensitized labeling of viral envelope-resident proteins occurs only upon their insertion into target membranes. Photosensitized labeling as a result of HIV-1 Env-mediated cell fusion showed the same kinetics as aqueous dye transfer. We have for the first time measured kinetics of HIV and SIV virus-cell fusion. HIV-1(MN) virions were about 10x less fusion active than SIVmne virions. SIV inactivated by aldrithiol-2 retained fusion activity similar to that seen with untreated virus. The relatively slow time course of SIV-cell fusion (t(1/2) = 19 min) indicates that the fusion events are stochastic. This feature provides a basis for understanding the mode of action of HIV/SIV entry inhibitors that target transition states.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11886244     DOI: 10.1006/viro.2001.1237

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

1.  Time-resolved imaging of HIV-1 Env-mediated lipid and content mixing between a single virion and cell membrane.

Authors:  Ruben M Markosyan; Fredric S Cohen; Grigory B Melikyan
Journal:  Mol Biol Cell       Date:  2005-09-29       Impact factor: 4.138

2.  Evaluation of "credit card" libraries for inhibition of HIV-1 gp41 fusogenic core formation.

Authors:  Yang Xu; Hong Lu; Jack P Kennedy; Xuxia Yan; Laura A McAllister; Noboru Yamamoto; Jason A Moss; Grant E Boldt; Shibo Jiang; Kim D Janda
Journal:  J Comb Chem       Date:  2006 Jul-Aug

3.  Rapid dissociation of HIV-1 from cultured cells severely limits infectivity assays, causes the inactivation ascribed to entry inhibitors, and masks the inherently high level of infectivity of virions.

Authors:  Emily J Platt; Susan L Kozak; James P Durnin; Thomas J Hope; David Kabat
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

4.  Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells.

Authors:  Mathias Viard; Isabella Parolini; Massimo Sargiacomo; Katia Fecchi; Carlo Ramoni; Sherimay Ablan; Francis W Ruscetti; Ji Ming Wang; Robert Blumenthal
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.

Authors:  Charline Giroud; Mariana Marin; Jason Hammonds; Paul Spearman; Gregory B Melikyan
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

6.  Inactivation of retroviruses with preservation of structural integrity by targeting the hydrophobic domain of the viral envelope.

Authors:  Yossef Raviv; Mathias Viard; Julian W Bess; Elena Chertova; Robert Blumenthal
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  Membrane-anchored inhibitory peptides capture human immunodeficiency virus type 1 gp41 conformations that engage the target membrane prior to fusion.

Authors:  Gregory B Melikyan; Marc Egelhofer; Dorothee von Laer
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 8.  HIV entry and envelope glycoprotein-mediated fusion.

Authors:  Robert Blumenthal; Stewart Durell; Mathias Viard
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

9.  An allosteric rheostat in HIV-1 gp120 reduces CCR5 stoichiometry required for membrane fusion and overcomes diverse entry limitations.

Authors:  Emily J Platt; James P Durnin; Ujwal Shinde; David Kabat
Journal:  J Mol Biol       Date:  2007-09-12       Impact factor: 5.469

10.  A high throughput Cre-lox activated viral membrane fusion assay identifies pharmacological inhibitors of HIV entry.

Authors:  Anthony M Esposito; Pamela Cheung; Talia H Swartz; Hongru Li; Tshidi Tsibane; Natasha D Durham; Christopher F Basler; Dan P Felsenfeld; Benjamin K Chen
Journal:  Virology       Date:  2016-01-21       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.